ChemLifeIntel
Access
ChemLifeIntel/Companies/C & A Naturistics

C & A Naturistics

HIGH RISKHQ: — · Private · Founded —
LISTINGPrivateFOUNDED0
FOCUS THERAPY AREAS
Manufacturer
COMPANY INTELLIGENCE SNAPSHOTlive
0
Manufacturing Sites
1
Intelligence Briefs
0
Active Regulatory Actions
HQ Country
NO ACTIVE REGULATORY ACTIONSClean compliance footprint across 0 monitored sites · HQ
View regulatory detail

INTELLIGENCE

Showing 1 of 1 briefs on C & A Naturistics
REGULATORY INTELLIGENCE·Warning Letter

FDA Mandates Class II Recall for C & A Naturistics' AK Forte Due to Undeclared Diclofenac and Acetaminophen

C & A Naturistics initiated a Class II recall for AK Forte Ortiga y Omega 3 due to undeclared diclofenac and acetaminophen, marketed without FDA approval. This event highlights critical supply chain and regulatory compliance failures. Procurement and regulatory teams must scrutinize suppliers, especially for products lacking proper authorization, to mitigate significant business and patient safety risks.

90-Day Activity
C & A NaturisticsAK Forte Ortiga y Omega 3 Cont. Neto 100 Tabletas, 400 mg
RMRohan Mehta· Senior Supply Chain Intelligence Analyst
2024-10-30